
About 10 yrs ago: An unlikely trio form a lifelong bond while students at George Washington University in DC. Catherine: the white gentile southern lass. Alondra: a brassy Latina from Brooklyn. Derrick: African-American special forces veteran. The Three Musketeers they call themselves.
Catherine's passion is medicine and headed off to UNC School of Medicine. Alondra wants to be a journalist, if she can keep her opinions in check and just report the news. Derrick goes to law school with ambitions of public service. Alondra and Derrick had become quite an item, but she broke it
off because she knew that her penchant for muckraking and her
reactionary temper wouldn't be the proper companion for a man who just
might end up in Congress.
Life goes as expected except for Alondra. Gets her newspaper job. Her looks and heritage get her noticed by network TV. She gets a gig as the morning anchor on a DC-based network with no interest in her opinions and forces her to just be a newsreader. When reading a story that the network has blatantly slanted away from the truth, she erupts on air. Bye bye TV job. She now works for an upcoming online news group, still in DC.
Today: Alondra is trying to get some confirmations of details of a new health care bill that will provide free meds for a variety of chronic conditions. She tries to get something, anything, from Senator Howell of Alabama who sits on the committee writing the bill. His pompous, arrogant attitude toward Alondra doesn't sit well, but it comes with the territory of Capitol Hill. After being brushed off, Alondra turns and runs into the newly elected congressman from NY.
Derrick Battle. Her ex.
Catherine is doing an OB/GYN residency in Chapel Hill where the residents have to do some work in a rural free clinic. She comes across an unusually large number of women with premature ovarian failure. Women in the 20's effectively becoming postmenopausal; sterile. She asks some of her former classmates in other residencies to send her details of their cases, accumulating a substantial case series. She notices two commonalities. First, all the women had taken a new contraceptive, Ovucontra from Rock Pharmaceuticals. Single shot. Once a year. 100% effective. Second, those afflicted were all women of color. She looks into the drug and the company and starts asking more questions. Questions that reach Rock Pharmaceuticals. She's spooked by what she has learned, contacts Alondra and they agree to meet over the upcoming weekend. Friday afternoon, Catherine's mother calls. Catherine was killed on Thursday night in a bungled robbery.
After Catherine's funeral, Alondra receives a thumb drive in the mail. From Catherine. Contains all her notes about what she'd found. Names of people involved in the drug's development, doctors overseeing the clinical trials. And her own developing case series of patients. Alondra wants to follow-up and not let Catherine's fears die with her. Alondra calls Rock's Director of R/D. Dead 2 months ago. Traffic accident. She calls the doctor who ran the Miami clinical trial. Drowned a few weeks ago. She sets up a Skype call with the Kenyan doctor who ran the African clinical trial site. He's also spooked. Too many women with premature ovarian failure. He won't use it. Starts to send her his notes when he's killed right in front of her eyes.
From here, it's a race to a truth that Alondra will not let go. She needs an insider. She needs internal Rock communications. She needs to get a sample of the drug. Rock Pharma stands to make billions because it's the only name-brand drug included in the new healthcare bill. But it goes farther and deeper than just money. She needs to connect the dots before she, too, ends up dead.
Got this via Netgalley. The short description sounded interesting. A dogged journalist, a medical mystery, a political thriller. Checks most of my boxes. After reading, I looked up Crista McHugh, a NYT bestselling author. Her genres are romance (contemporary, historical, paranormal), young adult, and fantasy. Not the kind of author generally reviewed the MRB boys.
But let me tell you, boys and girls. This book crackled with a level of authenticity that is usually associated with insider knowledge. You know, a book that might've been written by a former Big Pharma employee, an MD, or a former congressional staffer. Those sorts. You'd never know McHugh is a romance novelist. I was welded to my seat reading this. And when my Kindle wasn't in my hands, I was looking for reasons to stop what I was doing in order to get back to it. I was left stunned. Obviously, McHugh knows how to write. But a medical/political/journalist thriller? Who knew. Could've easily read this in one sitting.
Pick this one up. Anyone who likes thrillers based on investigative reporting, medicine, or politics will find this one right up their alley.
Available May 29, 2019
ECD
p.s. Only one thing that didn't fully ring true to me. From what I've seen, Big Pharma is, for the most part, out of the R/D business. They let independent startups do the basic research on new molecules - the expensive part of the process. When they find a new molecule or product that looks promising, they just buy out the company. Cheaper in the long run. But that's an incredibly minor quibble that doesn't detract from this terrific story.